Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-28
DOI
10.1186/s12933-019-0964-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Canagliflozin, an SGLT2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats
- (2019) Yukishige Kimura et al. Journal of Diabetes Investigation
- Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
- (2019) Salva R. Yurista et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats
- (2019) Ting-I Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
- (2018) Sarayut Lahnwong et al. Cardiovascular Diabetology
- Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) Rat
- (2018) Firas Younis et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: A systematic review and meta-analysis
- (2018) Muhammad Shariq Usman et al. European Journal of Preventive Cardiology
- Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
- (2018) Hao Zhou et al. Redox Biology
- Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat
- (2018) Chih-Chao Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn2+-transporters in cardiomyocytes from insulin-resistant metabolic syndrome rats through inhibition of oxidative stress
- (2018) Yusuf Olgar et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
- (2018) Aysegul Durak et al. Cardiovascular Diabetology
- Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
- (2018) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- First-dose effect of the SGLT2 inhibitor ipragliflozin on cardiovascular activity in spontaneously diabetic Torii fatty rats
- (2018) Shoji Takakura et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.
- (2018) Hiroto Oshima et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
- (2018) Laween Uthman et al. Frontiers in Physiology
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of empagliflozin in patients with diabetes and heart failure
- (2017) David Pham et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits
- (2017) Xiaowei Zhang et al. Journal of the American Heart Association
- Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus
- (2016) Huilin Tang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
- (2016) Hiroaki Kusaka et al. Cardiovascular Diabetology
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits
- (2016) Jiuchun Qiu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
- (2016) Dipak Kotecha et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mitochondrial Biogenesis Is Impaired in Osteoarthritis Chondrocytes but Reversible via Peroxisome Proliferator-Activated Receptor γ Coactivator 1α
- (2015) Yun Wang et al. Arthritis & Rheumatology
- Myocardial Contractile Dysfunction Is Associated With Impaired Mitochondrial Function and Dynamics in Type 2 Diabetic but Not in Obese Patients
- (2014) David Montaigne et al. CIRCULATION
- Probucol Prevents Atrial Remodeling by Inhibiting Oxidative Stress and TNF-α/NF-κB/TGF-β Signal Transduction Pathway in Alloxan-Induced Diabetic Rabbits
- (2014) HUAYING FU et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Atrial Remodeling and Atrial Fibrillation
- (2014) Stanley Nattel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Modeling type 2 diabetes in rats using high fat diet and streptozotocin
- (2014) Søs Skovsø Journal of Diabetes Investigation
- Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet
- (2014) Steven P Vickers et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart
- (2013) Wenjun Yan et al. BASIC RESEARCH IN CARDIOLOGY
- Production of Reactive Oxygen Species in the Diabetic Heart
- (2013) Yasushi Teshima et al. CIRCULATION JOURNAL
- Expression of Na+-d-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences
- (2012) Ivan Sabolić et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Progression of Ventricular Remodeling and Arrhythmia in the Primary Hyperoxidative State of Glutathione-Depleted Rats
- (2011) Sayaka Kurokawa et al. CIRCULATION JOURNAL
- Glucose-transporter–mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients
- (2010) Dirk von Lewinski et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats
- (2010) Pravinkumar Bhutada et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study
- (2009) X. Du et al. EUROPEAN HEART JOURNAL
- The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model
- (2009) Ming Zhang et al. Experimental Diabetes Research
- Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human Heart
- (2009) Ethan J. Anderson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of New-Onset Diabetes Mellitus on Development of Atrial Fibrillation and Heart Failure in High-Risk Hypertension (from the VALUE Trial)
- (2008) Tonje Amb Aksnes et al. AMERICAN JOURNAL OF CARDIOLOGY
- Extracellular Charge Adsorption Influences Intracellular Electrochemical Homeostasis in Amphibian Skeletal Muscle
- (2008) Arpan R. Mehta et al. BIOPHYSICAL JOURNAL
- Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome
- (2008) Heiko Bugger et al. CLINICAL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More